TheraNova Nordic ApS: Financial statements 2022
CVR: 39346788
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
TheraNova Nordic ApS (CVR 39346788) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -564,957 and a net result of DKK -446,249 compared with DKK 222,367 the year before. Equity in the 2022 report amounted to DKK 21,001. The solvency ratio was 5.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -564,957
- Profit/Loss
- DKK -446,249
- Equity
- DKK 21,001
- Total Assets
- DKK 364,723
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -565 t. | -446 t. | 21 t. | 1 |
| 2021 | - | 274 t. | 222 t. | 467 t. | 1 |
| 2020 | - | 442 t. | 253 t. | 245 t. | 1 |
Official annual report
Keep an eye on TheraNova Nordic ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout TheraNova Nordic ApS
TheraNova Nordic ApS is a Danish company of the type Anpartsselskab based in Fredericia, founded in 2018. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Terapishop DK ApS. The management consists of Gitte Anna Lasota. The company is owned by LASOTA HOLDING ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -8,001 and a net result of DKK 5,358 compared with DKK -70,464 the year before. Equity in the 2025 report amounted to DKK -29,376.